nodes	percent_of_prediction	percent_of_DWPC	metapath
Methylscopolamine bromide—Ageusia—Sunitinib—pancreatic cancer	0.00705	0.0441	CcSEcCtD
Methylscopolamine bromide—Ageusia—Docetaxel—pancreatic cancer	0.00401	0.0251	CcSEcCtD
Methylscopolamine bromide—Erectile dysfunction—Tamoxifen—pancreatic cancer	0.00385	0.0241	CcSEcCtD
Methylscopolamine bromide—Abdominal distension—Sunitinib—pancreatic cancer	0.00361	0.0226	CcSEcCtD
Methylscopolamine bromide—Abdominal distension—Irinotecan—pancreatic cancer	0.00297	0.0186	CcSEcCtD
Methylscopolamine bromide—Ageusia—Epirubicin—pancreatic cancer	0.00271	0.0169	CcSEcCtD
Methylscopolamine bromide—Ageusia—Doxorubicin—pancreatic cancer	0.00251	0.0157	CcSEcCtD
Methylscopolamine bromide—Dry mouth—Tamoxifen—pancreatic cancer	0.00243	0.0152	CcSEcCtD
Methylscopolamine bromide—Insomnia—Tamoxifen—pancreatic cancer	0.00215	0.0135	CcSEcCtD
Methylscopolamine bromide—Insomnia—Erlotinib—pancreatic cancer	0.00213	0.0133	CcSEcCtD
Methylscopolamine bromide—Dry mouth—Sunitinib—pancreatic cancer	0.00208	0.013	CcSEcCtD
Methylscopolamine bromide—Constipation—Tamoxifen—pancreatic cancer	0.00203	0.0127	CcSEcCtD
Methylscopolamine bromide—Constipation—Erlotinib—pancreatic cancer	0.00201	0.0126	CcSEcCtD
Methylscopolamine bromide—Urticaria—Tamoxifen—pancreatic cancer	0.00189	0.0118	CcSEcCtD
Methylscopolamine bromide—Vision blurred—Fluorouracil—pancreatic cancer	0.00186	0.0116	CcSEcCtD
Methylscopolamine bromide—Insomnia—Sunitinib—pancreatic cancer	0.00184	0.0115	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Tamoxifen—pancreatic cancer	0.00175	0.011	CcSEcCtD
Methylscopolamine bromide—Constipation—Sunitinib—pancreatic cancer	0.00174	0.0109	CcSEcCtD
Methylscopolamine bromide—Asthenia—Tamoxifen—pancreatic cancer	0.00171	0.0107	CcSEcCtD
Methylscopolamine bromide—Confusional state—Irinotecan—pancreatic cancer	0.00169	0.0106	CcSEcCtD
Methylscopolamine bromide—Asthenia—Erlotinib—pancreatic cancer	0.00169	0.0106	CcSEcCtD
Methylscopolamine bromide—Anaphylactic shock—Irinotecan—pancreatic cancer	0.00168	0.0105	CcSEcCtD
Methylscopolamine bromide—Anaphylactic shock—Gemcitabine—pancreatic cancer	0.00164	0.0102	CcSEcCtD
Methylscopolamine bromide—Confusional state—Fluorouracil—pancreatic cancer	0.00162	0.0101	CcSEcCtD
Methylscopolamine bromide—Anaphylactic shock—Fluorouracil—pancreatic cancer	0.00161	0.0101	CcSEcCtD
Methylscopolamine bromide—Dizziness—Tamoxifen—pancreatic cancer	0.00157	0.00984	CcSEcCtD
Methylscopolamine bromide—Tachycardia—Fluorouracil—pancreatic cancer	0.00157	0.00981	CcSEcCtD
Methylscopolamine bromide—Dizziness—Erlotinib—pancreatic cancer	0.00156	0.00973	CcSEcCtD
Methylscopolamine bromide—Insomnia—Irinotecan—pancreatic cancer	0.00152	0.00949	CcSEcCtD
Methylscopolamine bromide—Vomiting—Tamoxifen—pancreatic cancer	0.00151	0.00946	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Sunitinib—pancreatic cancer	0.0015	0.00939	CcSEcCtD
Methylscopolamine bromide—Vomiting—Erlotinib—pancreatic cancer	0.0015	0.00936	CcSEcCtD
Methylscopolamine bromide—Somnolence—Irinotecan—pancreatic cancer	0.00149	0.00933	CcSEcCtD
Methylscopolamine bromide—Headache—Tamoxifen—pancreatic cancer	0.00149	0.00932	CcSEcCtD
Methylscopolamine bromide—Insomnia—Gemcitabine—pancreatic cancer	0.00148	0.00925	CcSEcCtD
Methylscopolamine bromide—Headache—Erlotinib—pancreatic cancer	0.00147	0.00922	CcSEcCtD
Methylscopolamine bromide—Asthenia—Sunitinib—pancreatic cancer	0.00146	0.00914	CcSEcCtD
Methylscopolamine bromide—Insomnia—Fluorouracil—pancreatic cancer	0.00145	0.00909	CcSEcCtD
Methylscopolamine bromide—Somnolence—Gemcitabine—pancreatic cancer	0.00145	0.00909	CcSEcCtD
Methylscopolamine bromide—Constipation—Irinotecan—pancreatic cancer	0.00144	0.00898	CcSEcCtD
Methylscopolamine bromide—Somnolence—Fluorouracil—pancreatic cancer	0.00143	0.00894	CcSEcCtD
Methylscopolamine bromide—Nausea—Tamoxifen—pancreatic cancer	0.00141	0.00884	CcSEcCtD
Methylscopolamine bromide—Constipation—Gemcitabine—pancreatic cancer	0.0014	0.00874	CcSEcCtD
Methylscopolamine bromide—Nausea—Erlotinib—pancreatic cancer	0.0014	0.00874	CcSEcCtD
Methylscopolamine bromide—Abdominal distension—Epirubicin—pancreatic cancer	0.00139	0.00866	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Irinotecan—pancreatic cancer	0.00138	0.00865	CcSEcCtD
Methylscopolamine bromide—Dizziness—Sunitinib—pancreatic cancer	0.00135	0.00843	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Gemcitabine—pancreatic cancer	0.00135	0.00842	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Fluorouracil—pancreatic cancer	0.00132	0.00828	CcSEcCtD
Methylscopolamine bromide—Vomiting—Sunitinib—pancreatic cancer	0.0013	0.0081	CcSEcCtD
Methylscopolamine bromide—Abdominal distension—Doxorubicin—pancreatic cancer	0.00128	0.00802	CcSEcCtD
Methylscopolamine bromide—Urticaria—Fluorouracil—pancreatic cancer	0.00128	0.00799	CcSEcCtD
Methylscopolamine bromide—Headache—Sunitinib—pancreatic cancer	0.00128	0.00798	CcSEcCtD
Methylscopolamine bromide—Palpitations—Docetaxel—pancreatic cancer	0.00126	0.00786	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Irinotecan—pancreatic cancer	0.00124	0.00773	CcSEcCtD
Methylscopolamine bromide—Drowsiness—Epirubicin—pancreatic cancer	0.00123	0.00767	CcSEcCtD
Methylscopolamine bromide—Nausea—Sunitinib—pancreatic cancer	0.00121	0.00757	CcSEcCtD
Methylscopolamine bromide—Asthenia—Irinotecan—pancreatic cancer	0.0012	0.00753	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Fluorouracil—pancreatic cancer	0.00118	0.00741	CcSEcCtD
Methylscopolamine bromide—Dry mouth—Docetaxel—pancreatic cancer	0.00118	0.0074	CcSEcCtD
Methylscopolamine bromide—Asthenia—Gemcitabine—pancreatic cancer	0.00117	0.00734	CcSEcCtD
Methylscopolamine bromide—Confusional state—Docetaxel—pancreatic cancer	0.00117	0.00732	CcSEcCtD
Methylscopolamine bromide—Anaphylactic shock—Docetaxel—pancreatic cancer	0.00116	0.00726	CcSEcCtD
Methylscopolamine bromide—Drowsiness—Doxorubicin—pancreatic cancer	0.00114	0.0071	CcSEcCtD
Methylscopolamine bromide—Tachycardia—Docetaxel—pancreatic cancer	0.00113	0.00708	CcSEcCtD
Methylscopolamine bromide—Dizziness—Irinotecan—pancreatic cancer	0.00111	0.00694	CcSEcCtD
Methylscopolamine bromide—Vomiting—Irinotecan—pancreatic cancer	0.00107	0.00667	CcSEcCtD
Methylscopolamine bromide—Dizziness—Fluorouracil—pancreatic cancer	0.00106	0.00665	CcSEcCtD
Methylscopolamine bromide—Headache—Irinotecan—pancreatic cancer	0.00105	0.00658	CcSEcCtD
Methylscopolamine bromide—Insomnia—Docetaxel—pancreatic cancer	0.00105	0.00656	CcSEcCtD
Methylscopolamine bromide—Vomiting—Gemcitabine—pancreatic cancer	0.00104	0.0065	CcSEcCtD
Methylscopolamine bromide—Somnolence—Docetaxel—pancreatic cancer	0.00103	0.00645	CcSEcCtD
Methylscopolamine bromide—Headache—Gemcitabine—pancreatic cancer	0.00102	0.0064	CcSEcCtD
Methylscopolamine bromide—Vomiting—Fluorouracil—pancreatic cancer	0.00102	0.00639	CcSEcCtD
Methylscopolamine bromide—Headache—Fluorouracil—pancreatic cancer	0.00101	0.0063	CcSEcCtD
Methylscopolamine bromide—Nausea—Irinotecan—pancreatic cancer	0.000997	0.00623	CcSEcCtD
Methylscopolamine bromide—Constipation—Docetaxel—pancreatic cancer	0.000992	0.0062	CcSEcCtD
Methylscopolamine bromide—Nausea—Gemcitabine—pancreatic cancer	0.000971	0.00607	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Docetaxel—pancreatic cancer	0.000956	0.00598	CcSEcCtD
Methylscopolamine bromide—Nausea—Fluorouracil—pancreatic cancer	0.000955	0.00597	CcSEcCtD
Methylscopolamine bromide—Tension—Epirubicin—pancreatic cancer	0.000941	0.00588	CcSEcCtD
Methylscopolamine bromide—Nervousness—Epirubicin—pancreatic cancer	0.000931	0.00582	CcSEcCtD
Methylscopolamine bromide—Vision blurred—Epirubicin—pancreatic cancer	0.000904	0.00565	CcSEcCtD
Methylscopolamine bromide—Tension—Doxorubicin—pancreatic cancer	0.000871	0.00544	CcSEcCtD
Methylscopolamine bromide—Nervousness—Doxorubicin—pancreatic cancer	0.000862	0.00539	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Docetaxel—pancreatic cancer	0.000855	0.00535	CcSEcCtD
Methylscopolamine bromide—Palpitations—Epirubicin—pancreatic cancer	0.000847	0.0053	CcSEcCtD
Methylscopolamine bromide—Vision blurred—Doxorubicin—pancreatic cancer	0.000836	0.00523	CcSEcCtD
Methylscopolamine bromide—Asthenia—Docetaxel—pancreatic cancer	0.000832	0.00521	CcSEcCtD
Methylscopolamine bromide—Dry mouth—Epirubicin—pancreatic cancer	0.000798	0.00499	CcSEcCtD
Methylscopolamine bromide—Confusional state—Epirubicin—pancreatic cancer	0.000789	0.00493	CcSEcCtD
Methylscopolamine bromide—Palpitations—Doxorubicin—pancreatic cancer	0.000784	0.0049	CcSEcCtD
Methylscopolamine bromide—Anaphylactic shock—Epirubicin—pancreatic cancer	0.000783	0.00489	CcSEcCtD
Methylscopolamine bromide—Dizziness—Docetaxel—pancreatic cancer	0.000767	0.0048	CcSEcCtD
Methylscopolamine bromide—Tachycardia—Epirubicin—pancreatic cancer	0.000764	0.00478	CcSEcCtD
Methylscopolamine bromide—Dry mouth—Doxorubicin—pancreatic cancer	0.000739	0.00462	CcSEcCtD
Methylscopolamine bromide—Vomiting—Docetaxel—pancreatic cancer	0.000738	0.00461	CcSEcCtD
Methylscopolamine bromide—Confusional state—Doxorubicin—pancreatic cancer	0.00073	0.00457	CcSEcCtD
Methylscopolamine bromide—Headache—Docetaxel—pancreatic cancer	0.000727	0.00455	CcSEcCtD
Methylscopolamine bromide—Anaphylactic shock—Doxorubicin—pancreatic cancer	0.000724	0.00453	CcSEcCtD
Methylscopolamine bromide—Insomnia—Epirubicin—pancreatic cancer	0.000708	0.00443	CcSEcCtD
Methylscopolamine bromide—Tachycardia—Doxorubicin—pancreatic cancer	0.000707	0.00442	CcSEcCtD
Methylscopolamine bromide—Somnolence—Epirubicin—pancreatic cancer	0.000696	0.00435	CcSEcCtD
Methylscopolamine bromide—Nausea—Docetaxel—pancreatic cancer	0.000689	0.00431	CcSEcCtD
Methylscopolamine bromide—Constipation—Epirubicin—pancreatic cancer	0.000669	0.00418	CcSEcCtD
Methylscopolamine bromide—Insomnia—Doxorubicin—pancreatic cancer	0.000655	0.0041	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Epirubicin—pancreatic cancer	0.000645	0.00403	CcSEcCtD
Methylscopolamine bromide—Somnolence—Doxorubicin—pancreatic cancer	0.000644	0.00403	CcSEcCtD
Methylscopolamine bromide—Urticaria—Epirubicin—pancreatic cancer	0.000622	0.00389	CcSEcCtD
Methylscopolamine bromide—Constipation—Doxorubicin—pancreatic cancer	0.000619	0.00387	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Doxorubicin—pancreatic cancer	0.000597	0.00373	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Epirubicin—pancreatic cancer	0.000577	0.00361	CcSEcCtD
Methylscopolamine bromide—Urticaria—Doxorubicin—pancreatic cancer	0.000575	0.0036	CcSEcCtD
Methylscopolamine bromide—Asthenia—Epirubicin—pancreatic cancer	0.000562	0.00351	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Doxorubicin—pancreatic cancer	0.000534	0.00334	CcSEcCtD
Methylscopolamine bromide—Asthenia—Doxorubicin—pancreatic cancer	0.00052	0.00325	CcSEcCtD
Methylscopolamine bromide—Dizziness—Epirubicin—pancreatic cancer	0.000518	0.00324	CcSEcCtD
Methylscopolamine bromide—Vomiting—Epirubicin—pancreatic cancer	0.000498	0.00311	CcSEcCtD
Methylscopolamine bromide—Headache—Epirubicin—pancreatic cancer	0.00049	0.00307	CcSEcCtD
Methylscopolamine bromide—Dizziness—Doxorubicin—pancreatic cancer	0.000479	0.00299	CcSEcCtD
Methylscopolamine bromide—Nausea—Epirubicin—pancreatic cancer	0.000465	0.00291	CcSEcCtD
Methylscopolamine bromide—Vomiting—Doxorubicin—pancreatic cancer	0.00046	0.00288	CcSEcCtD
Methylscopolamine bromide—Headache—Doxorubicin—pancreatic cancer	0.000454	0.00284	CcSEcCtD
Methylscopolamine bromide—Nausea—Doxorubicin—pancreatic cancer	0.00043	0.00269	CcSEcCtD
Methylscopolamine bromide—CHRM2—Signaling Pathways—GLP1R—pancreatic cancer	0.000342	0.000407	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—CNR2—pancreatic cancer	0.000342	0.000407	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR ligand binding—CXCL8—pancreatic cancer	0.000341	0.000406	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—GCG—pancreatic cancer	0.000341	0.000406	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—CCKAR—pancreatic cancer	0.00034	0.000405	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—CCKAR—pancreatic cancer	0.000339	0.000404	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—CCKAR—pancreatic cancer	0.000336	0.0004	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—GPCR downstream signaling—PIK3CD—pancreatic cancer	0.000331	0.000395	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—JAG2—pancreatic cancer	0.00033	0.000393	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—JAG2—pancreatic cancer	0.000329	0.000392	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—JAG2—pancreatic cancer	0.000326	0.000388	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—MEN1—pancreatic cancer	0.000325	0.000387	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—AGTR1—pancreatic cancer	0.000325	0.000387	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—MEN1—pancreatic cancer	0.000324	0.000386	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—MEN1—pancreatic cancer	0.000321	0.000382	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—STK11—pancreatic cancer	0.00032	0.000381	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—SHH—pancreatic cancer	0.00031	0.00037	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—SHH—pancreatic cancer	0.000309	0.000368	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—NOTCH4—pancreatic cancer	0.000308	0.000367	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—NOTCH4—pancreatic cancer	0.000308	0.000366	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—IAPP—pancreatic cancer	0.000307	0.000365	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—SHH—pancreatic cancer	0.000306	0.000365	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—IAPP—pancreatic cancer	0.000306	0.000364	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—NOTCH4—pancreatic cancer	0.000305	0.000362	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—IAPP—pancreatic cancer	0.000303	0.00036	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling by GPCR—PIK3CD—pancreatic cancer	0.000301	0.000358	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—CD44—pancreatic cancer	0.000298	0.000355	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—PTHLH—pancreatic cancer	0.000294	0.00035	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—PTCH1—pancreatic cancer	0.000294	0.00035	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—PTHLH—pancreatic cancer	0.000293	0.000349	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—PTCH1—pancreatic cancer	0.000293	0.000349	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—PTHLH—pancreatic cancer	0.000291	0.000346	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—PTCH1—pancreatic cancer	0.000291	0.000346	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—GPCR downstream signaling—PIK3CB—pancreatic cancer	0.000289	0.000344	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—GCG—pancreatic cancer	0.000286	0.00034	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—SMAD4—pancreatic cancer	0.000281	0.000334	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—GPCR downstream signaling—CXCL8—pancreatic cancer	0.000278	0.00033	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—HES1—pancreatic cancer	0.000274	0.000326	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—SST—pancreatic cancer	0.000269	0.00032	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—STK11—pancreatic cancer	0.000269	0.00032	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—SST—pancreatic cancer	0.000268	0.000319	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—SST—pancreatic cancer	0.000266	0.000316	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR downstream signaling—PIK3CG—pancreatic cancer	0.000265	0.000316	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR downstream signaling—PIK3CG—pancreatic cancer	0.000265	0.000315	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—JAG1—pancreatic cancer	0.000263	0.000314	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—JAG1—pancreatic cancer	0.000263	0.000313	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling by GPCR—PIK3CB—pancreatic cancer	0.000262	0.000312	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—NOTCH3—pancreatic cancer	0.000262	0.000312	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR downstream signaling—PIK3CG—pancreatic cancer	0.000262	0.000312	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—NOTCH3—pancreatic cancer	0.000261	0.000311	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—JAG1—pancreatic cancer	0.00026	0.00031	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—NOTCH3—pancreatic cancer	0.000259	0.000308	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling by GPCR—CXCL8—pancreatic cancer	0.000252	0.0003	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—CNR1—pancreatic cancer	0.000248	0.000296	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—CNR1—pancreatic cancer	0.000248	0.000295	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—CNR1—pancreatic cancer	0.000245	0.000292	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—PIK3CG—pancreatic cancer	0.000241	0.000287	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—PIK3CG—pancreatic cancer	0.00024	0.000286	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—TERT—pancreatic cancer	0.00024	0.000286	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—GCG—pancreatic cancer	0.00024	0.000286	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—GCG—pancreatic cancer	0.000239	0.000285	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—PIK3CG—pancreatic cancer	0.000238	0.000283	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—GCG—pancreatic cancer	0.000237	0.000282	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR downstream signaling—PIK3CD—pancreatic cancer	0.000233	0.000278	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR downstream signaling—PIK3CD—pancreatic cancer	0.000233	0.000277	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—TYMS—pancreatic cancer	0.000231	0.000275	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR downstream signaling—PIK3CD—pancreatic cancer	0.00023	0.000274	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—HIF1A—pancreatic cancer	0.00023	0.000273	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—TSC2—pancreatic cancer	0.000229	0.000273	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—AGTR1—pancreatic cancer	0.000229	0.000272	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—AGTR1—pancreatic cancer	0.000228	0.000272	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—AGTR1—pancreatic cancer	0.000226	0.000269	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—STK11—pancreatic cancer	0.000226	0.000268	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—STK11—pancreatic cancer	0.000225	0.000268	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—APOE—pancreatic cancer	0.000224	0.000267	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—STK11—pancreatic cancer	0.000223	0.000265	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—KDR—pancreatic cancer	0.00022	0.000261	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—PIK3CD—pancreatic cancer	0.000212	0.000252	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—PIK3CD—pancreatic cancer	0.000211	0.000251	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—PIK3CD—pancreatic cancer	0.000209	0.000249	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—NFKBIA—pancreatic cancer	0.000209	0.000249	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—NOTCH1—pancreatic cancer	0.000207	0.000246	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR downstream signaling—PIK3CB—pancreatic cancer	0.000203	0.000242	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR downstream signaling—PIK3CB—pancreatic cancer	0.000203	0.000241	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—PIK3CG—pancreatic cancer	0.000202	0.000241	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling by GPCR—NRAS—pancreatic cancer	0.000202	0.000241	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR downstream signaling—PIK3CB—pancreatic cancer	0.000201	0.000239	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—EGF—pancreatic cancer	0.0002	0.000238	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—SMAD4—pancreatic cancer	0.000198	0.000235	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—SMAD4—pancreatic cancer	0.000197	0.000234	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR downstream signaling—CXCL8—pancreatic cancer	0.000195	0.000233	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—SMAD4—pancreatic cancer	0.000195	0.000232	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR downstream signaling—CXCL8—pancreatic cancer	0.000195	0.000232	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR downstream signaling—CXCL8—pancreatic cancer	0.000193	0.00023	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—HES1—pancreatic cancer	0.000193	0.00023	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—HES1—pancreatic cancer	0.000192	0.000229	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—HES1—pancreatic cancer	0.00019	0.000227	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—APOE—pancreatic cancer	0.000188	0.000224	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—PIK3CB—pancreatic cancer	0.000185	0.00022	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling by GPCR—EGFR—pancreatic cancer	0.000184	0.000219	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—PIK3CB—pancreatic cancer	0.000184	0.000219	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—PIK3CB—pancreatic cancer	0.000182	0.000217	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—PIK3CD—pancreatic cancer	0.000178	0.000212	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—CXCL8—pancreatic cancer	0.000178	0.000211	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—CXCL8—pancreatic cancer	0.000177	0.000211	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—GPCR downstream signaling—PIK3CA—pancreatic cancer	0.000176	0.00021	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—CXCL8—pancreatic cancer	0.000175	0.000209	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling by GPCR—KRAS—pancreatic cancer	0.000174	0.000207	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—PIK3CG—pancreatic cancer	0.00017	0.000202	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—TERT—pancreatic cancer	0.000169	0.000201	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—TERT—pancreatic cancer	0.000168	0.000201	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—TERT—pancreatic cancer	0.000167	0.000199	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—PPARG—pancreatic cancer	0.000164	0.000195	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—HIF1A—pancreatic cancer	0.000162	0.000192	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—TSC2—pancreatic cancer	0.000161	0.000192	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—HIF1A—pancreatic cancer	0.000161	0.000192	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—TSC2—pancreatic cancer	0.000161	0.000191	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling by GPCR—PIK3CA—pancreatic cancer	0.00016	0.00019	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—HIF1A—pancreatic cancer	0.00016	0.00019	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—TSC2—pancreatic cancer	0.000159	0.000189	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—APOE—pancreatic cancer	0.000158	0.000188	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—APOE—pancreatic cancer	0.000157	0.000187	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—APOE—pancreatic cancer	0.000156	0.000185	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—PIK3CB—pancreatic cancer	0.000155	0.000184	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—KDR—pancreatic cancer	0.000155	0.000184	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—KDR—pancreatic cancer	0.000154	0.000183	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—KDR—pancreatic cancer	0.000153	0.000182	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—PIK3CD—pancreatic cancer	0.000149	0.000178	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—CXCL8—pancreatic cancer	0.000149	0.000177	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling by GPCR—HRAS—pancreatic cancer	0.000148	0.000176	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—NFKBIA—pancreatic cancer	0.000147	0.000175	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—NFKBIA—pancreatic cancer	0.000147	0.000174	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—NOTCH1—pancreatic cancer	0.000146	0.000173	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—NOTCH1—pancreatic cancer	0.000145	0.000173	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—NFKBIA—pancreatic cancer	0.000145	0.000173	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—GPCR downstream signaling—AKT1—pancreatic cancer	0.000144	0.000171	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—NOTCH1—pancreatic cancer	0.000144	0.000171	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—CASP3—pancreatic cancer	0.000143	0.00017	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—PIK3CG—pancreatic cancer	0.000142	0.00017	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—NRAS—pancreatic cancer	0.000142	0.00017	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—PIK3CG—pancreatic cancer	0.000142	0.000169	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—NRAS—pancreatic cancer	0.000142	0.000169	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—EGF—pancreatic cancer	0.000141	0.000168	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—PIK3CG—pancreatic cancer	0.000141	0.000167	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—NRAS—pancreatic cancer	0.000141	0.000167	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—EGF—pancreatic cancer	0.00014	0.000167	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—EGF—pancreatic cancer	0.000139	0.000165	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—CCND1—pancreatic cancer	0.000139	0.000165	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—CTNNB1—pancreatic cancer	0.000137	0.000164	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—MMP9—pancreatic cancer	0.000135	0.00016	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—PTEN—pancreatic cancer	0.000134	0.000159	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling by GPCR—AKT1—pancreatic cancer	0.000131	0.000156	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—PIK3CB—pancreatic cancer	0.00013	0.000155	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—EGFR—pancreatic cancer	0.00013	0.000154	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—EGFR—pancreatic cancer	0.000129	0.000154	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—PTGS2—pancreatic cancer	0.000129	0.000153	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—EGFR—pancreatic cancer	0.000128	0.000152	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—PIK3CD—pancreatic cancer	0.000125	0.000149	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—PIK3CD—pancreatic cancer	0.000125	0.000149	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—SRC—pancreatic cancer	0.000124	0.000148	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR downstream signaling—PIK3CA—pancreatic cancer	0.000124	0.000148	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR downstream signaling—PIK3CA—pancreatic cancer	0.000124	0.000147	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—PIK3CD—pancreatic cancer	0.000124	0.000147	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—KRAS—pancreatic cancer	0.000123	0.000146	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR downstream signaling—PIK3CA—pancreatic cancer	0.000122	0.000146	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—KRAS—pancreatic cancer	0.000122	0.000145	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—KRAS—pancreatic cancer	0.000121	0.000144	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—VEGFA—pancreatic cancer	0.000121	0.000144	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—STAT3—pancreatic cancer	0.00012	0.000143	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—NRAS—pancreatic cancer	0.000119	0.000142	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—PIK3CA—pancreatic cancer	0.000113	0.000134	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—PTEN—pancreatic cancer	0.000112	0.000134	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—PIK3CA—pancreatic cancer	0.000112	0.000134	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—MYC—pancreatic cancer	0.000111	0.000132	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—PIK3CA—pancreatic cancer	0.000111	0.000132	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—TGFB1—pancreatic cancer	0.000111	0.000132	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—PIK3CB—pancreatic cancer	0.000109	0.00013	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—EGFR—pancreatic cancer	0.000109	0.00013	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—PIK3CB—pancreatic cancer	0.000109	0.000129	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—PIK3CB—pancreatic cancer	0.000108	0.000128	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—CXCL8—pancreatic cancer	0.000105	0.000125	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—CXCL8—pancreatic cancer	0.000105	0.000124	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—HRAS—pancreatic cancer	0.000104	0.000124	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—HRAS—pancreatic cancer	0.000104	0.000124	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—CXCL8—pancreatic cancer	0.000104	0.000123	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—HRAS—pancreatic cancer	0.000103	0.000122	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—KRAS—pancreatic cancer	0.000103	0.000122	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR downstream signaling—AKT1—pancreatic cancer	0.000101	0.000121	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR downstream signaling—AKT1—pancreatic cancer	0.000101	0.00012	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—CASP3—pancreatic cancer	0.0001	0.000119	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—CASP3—pancreatic cancer	0.0001	0.000119	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR downstream signaling—AKT1—pancreatic cancer	0.0001	0.000119	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—CASP3—pancreatic cancer	9.91e-05	0.000118	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—CCND1—pancreatic cancer	9.77e-05	0.000116	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—CCND1—pancreatic cancer	9.74e-05	0.000116	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—CTNNB1—pancreatic cancer	9.67e-05	0.000115	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—CCND1—pancreatic cancer	9.64e-05	0.000115	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—CTNNB1—pancreatic cancer	9.64e-05	0.000115	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—CTNNB1—pancreatic cancer	9.55e-05	0.000114	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—MMP9—pancreatic cancer	9.48e-05	0.000113	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—MMP9—pancreatic cancer	9.45e-05	0.000113	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—PIK3CA—pancreatic cancer	9.45e-05	0.000112	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—PTEN—pancreatic cancer	9.43e-05	0.000112	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—PTEN—pancreatic cancer	9.4e-05	0.000112	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—MMP9—pancreatic cancer	9.36e-05	0.000111	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—PTEN—pancreatic cancer	9.31e-05	0.000111	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—AKT1—pancreatic cancer	9.2e-05	0.00011	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—AKT1—pancreatic cancer	9.17e-05	0.000109	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—TP53—pancreatic cancer	9.14e-05	0.000109	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—AKT1—pancreatic cancer	9.08e-05	0.000108	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—SRC—pancreatic cancer	8.74e-05	0.000104	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—HRAS—pancreatic cancer	8.74e-05	0.000104	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—SRC—pancreatic cancer	8.72e-05	0.000104	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—SRC—pancreatic cancer	8.63e-05	0.000103	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—VEGFA—pancreatic cancer	8.52e-05	0.000101	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—VEGFA—pancreatic cancer	8.49e-05	0.000101	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—STAT3—pancreatic cancer	8.43e-05	0.0001	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—NRAS—pancreatic cancer	8.41e-05	0.0001	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—VEGFA—pancreatic cancer	8.41e-05	0.0001	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—STAT3—pancreatic cancer	8.41e-05	0.0001	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—NRAS—pancreatic cancer	8.39e-05	9.98e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—STAT3—pancreatic cancer	8.32e-05	9.91e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—NRAS—pancreatic cancer	8.3e-05	9.89e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—PIK3CA—pancreatic cancer	7.93e-05	9.44e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—MYC—pancreatic cancer	7.84e-05	9.33e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—TGFB1—pancreatic cancer	7.82e-05	9.31e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—MYC—pancreatic cancer	7.81e-05	9.3e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—TGFB1—pancreatic cancer	7.79e-05	9.28e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—MYC—pancreatic cancer	7.74e-05	9.21e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—AKT1—pancreatic cancer	7.72e-05	9.19e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—TGFB1—pancreatic cancer	7.72e-05	9.19e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—EGFR—pancreatic cancer	7.66e-05	9.12e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—EGFR—pancreatic cancer	7.64e-05	9.09e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—EGFR—pancreatic cancer	7.57e-05	9.01e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—KRAS—pancreatic cancer	7.24e-05	8.62e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—KRAS—pancreatic cancer	7.22e-05	8.59e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—KRAS—pancreatic cancer	7.15e-05	8.51e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—PIK3CA—pancreatic cancer	6.65e-05	7.92e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—PIK3CA—pancreatic cancer	6.63e-05	7.89e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—PIK3CA—pancreatic cancer	6.57e-05	7.82e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—AKT1—pancreatic cancer	6.48e-05	7.71e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—TP53—pancreatic cancer	6.44e-05	7.66e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—TP53—pancreatic cancer	6.41e-05	7.64e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—TP53—pancreatic cancer	6.35e-05	7.56e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—HRAS—pancreatic cancer	6.15e-05	7.33e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—HRAS—pancreatic cancer	6.13e-05	7.3e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—HRAS—pancreatic cancer	6.08e-05	7.23e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—AKT1—pancreatic cancer	5.43e-05	6.47e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—AKT1—pancreatic cancer	5.42e-05	6.45e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—AKT1—pancreatic cancer	5.36e-05	6.39e-05	CbGpPWpGaD
